Essity Completes Acquisition of Remaining 25 percent Share in ABIGO Medical

The process following the acquisition of the remaining 25 percent of the shares of ABIGO Medical AB is completed and the company is now a wholly owned subsidiary of Essity. As per the terms of the transaction, ABIGO Medicals pharma business has been divested and sold to the company’s founder Jan G. Smith.

ABIGO Medical is a Swedish medical solutions company with its head office in Gothenburg, Sweden. The company has about 170 employees. Essity acquired 75 percent of ABIGO Medical in February 2020. ABIGO Medical develops, manufactures and markets products including the Sorbact technology, which is a clinically established innovation for advanced wound care. In the first quarter of 2021, Essity’s organic net sales in wound care increased 2.1 percent.

Back to Tissue360 Newsletter